<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="736">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04717024</url>
  </required_header>
  <id_info>
    <org_study_id>NWCT20-SS-002</org_study_id>
    <nct_id>NCT04717024</nct_id>
  </id_info>
  <brief_title>The Nanowear Wearable Covid-19 Observational and Analysis Trend</brief_title>
  <acronym>NanoCOAT</acronym>
  <official_title>The Nanowear Wearable Covid-19 Observational and Analysis Trend</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanowear Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nanowear Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The NanoCOAT study is a multi-center, prospective, non-randomized, feasibility,&#xD;
      observational, non-significant risk study. The NanoCOAT study will enroll a minimum of 10 and&#xD;
      a maximum of 100 subjects in a potential for a multi-site in order to collect data and&#xD;
      analyze physiological and biometric trends due to Covid-19.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 15, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Hosptialized patient data</measure>
    <time_frame>up to 30 days of monitoring leading to discharge or admission to ICU</time_frame>
    <description>The primary study endpoint is adequate collection of hospitalized COVID 19 patient health metric data through the Nanowear WMDRS</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Trends in COVID 19 exacerbation</measure>
    <time_frame>up to 30 days of monitoring leading to discharge or admission to ICU</time_frame>
    <description>Exploratory information will be used to compare the signals obtained from the device to the severity of Covid-19 as measured by clinical evaluation</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Covid19</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Observational Study - no intervention</intervention_name>
    <description>Observational Study - no intervention</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects of legal age to give informed consent who are currently or recently hospitalized&#xD;
        with a primary diagnosis of Covid-19&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject has provided informed consent&#xD;
&#xD;
          -  Male or female over the age of 18 years&#xD;
&#xD;
          -  The patient is currently hospitalized with a primary diagnosis of Covid-19&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject is unwilling or unable to wear the vest during hospitalization.&#xD;
&#xD;
          -  Subjects who are pregnant.&#xD;
&#xD;
          -  Subject is intubated or admitted to ICU&#xD;
&#xD;
          -  Subject has an implantable cardiac device (i.e pacemaker or internal cardioverter&#xD;
             defibrillator)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hackensack University Medical Center</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Patricia Arakelian, RN, BSN, CCRP</last_name>
      <phone>551-996-5722</phone>
      <email>Patricia.Arakelian@hackensackmeridian.org</email>
    </contact>
    <investigator>
      <last_name>Sameer Jamal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maimonides Medical Center</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rukshana Hossain, MPH</last_name>
      <phone>718-283-8693</phone>
      <email>RHossain@maimonidesmed.org</email>
    </contact>
    <investigator>
      <last_name>Sergey Motov, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>John D Marshall, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 19, 2021</study_first_submitted>
  <study_first_submitted_qc>January 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 20, 2021</study_first_posted>
  <last_update_submitted>January 19, 2021</last_update_submitted>
  <last_update_submitted_qc>January 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

